MedTrace Logo

Curcumin Biomarker Trial in Head and Neck Cancer

NCT01160302 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2016-03-02

No results posted yet for this study

Summary

There is considerable evidence that turmeric consumption may have a protective effect against cancer progression. The purpose of this study is to examine the short-term effects of supplementation with a turmeric extract, Curcumin C3 Complex®, on biomarkers of head and neck squamous cell carcinoma (HNSCC).

Conditions

Interventions

DRUG

Microgranular Curcumin C3 Complex®

4 grams twice daily for 21-28 days

Sponsors & Collaborators

  • Feist-Weiller Cancer Center at Louisiana State University Health Sciences

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • Louisiana State University Health Sciences Center Shreveport

    lead OTHER

Principal Investigators

  • Cherie-Ann O Nathan, MD, FACS · LSUHSC-Shreveport and Feist-Weiller Cancer Center

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01160302 on ClinicalTrials.gov